Abstract
Cantú syndrome is a multisystem disorder caused by gain-of-function (GOF) mutations in KCNJ8 and ABCC9, the genes encoding the pore-forming inward rectifier Kir6.1 and regulatory sulfonylurea receptor SUR2B subunits of vascular ATP-sensitive K+ channels (KATP). In this study, we investigated the effects of Cantú syndrome on the vascular endothelium using mutant mice that model the disease. We found that endothelium-dependent dilation was impaired in small mesenteric arteries from Cantú mice. Loss of endothelium-dependent vasodilation led to increased vasoconstriction in response to intraluminal pressure and to the adrenergic receptor agonist phenylephrine. We also found that KATP GOF and acute activation of KATP channels with pinacidil increased the amplitude and frequency of wave-like Ca2+ events that were generated in the endothelium in response to the vasodilator agonist carbachol (CCh). Elevated cytosolic Ca2+ signaling activity in arterial endothelial cells from Cantú mice was associated with high mitochondrial [Ca2+], reactive oxygen species (ROS) generation, and peroxynitrite levels. Scavenging intracellular and mitochondrial ROS restored endothelium-dependent vasodilation in the arteries of mice with KATP GOF mutations. We conclude that mitochondrial Ca2+ overload and ROS generation cause endothelial dysfunction in mice with Cantú syndrome. This study was supported by grants from NHLBI (R35HL155008) and NIGMS (P20GM130459) to S.E., and NIH (R35HL140024) to C.G.N., and NIH (R00HL150277) to C.M. The Transgenic Genotyping and Phenotyping Core and the High Spatial and Temporal Resolution Imaging Core at the COBRE Center for Molecular and Cellular Signaling in the Cardiovascular System, University of Nevada, Reno is maintained by grants from NIH/NIGMS (P20GM130459). This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.